Kintor Pharmaceutical Limited (9939.HK)

HKD 1.31

(9.17%)

Net Income Summary of Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limited's latest annual net income in 2023 was -1.06 Billion CNY , down -11.15% from previous year.
Kintor Pharmaceutical Limited's latest quarterly net income in 2023 FY was -1.06 Billion CNY , down -11.15% from previous quarter.
Kintor Pharmaceutical Limited reported an annual net income of -954.36 Million CNY in 2022, down -113232.7% from previous year.
Kintor Pharmaceutical Limited reported an annual net income of -842.09 Thousand CNY in 2021, up 99.83% from previous year.
Kintor Pharmaceutical Limited reported a quarterly net income of -212.11 Thousand CNY for 2023 Q2, up 51.34% from previous quarter.
Kintor Pharmaceutical Limited reported a quarterly net income of -1.06 Billion CNY for 2023 FY, down -11.15% from previous quarter.

Annual Net Income Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Net Income of Kintor Pharmaceutical Limited (2023 - 2014)

Year	Net Income	Net Income Growth
2023	-1.06 Billion CNY	-11.15%
2022	-954.36 Million CNY	-113232.7%
2021	-842.09 Thousand CNY	99.83%
2020	-508.3 Million CNY	-118.55%
2019	-232.57 Million CNY	-214288.3%
2018	-108.48 Thousand CNY	99.77%
2017	-46.21 Million CNY	14.77%
2016	-54.22 Million CNY	-373.96%
2015	-11.44 Million CNY	-37.09%
2014	-8.34 Million CNY	0.0%

Year	Net Income	Net Income Growth
2023 Q4	-848.7 Thousand CNY	-300.12%
2023 Q2	-212.11 Thousand CNY	51.34%
2023 FY	-1.06 Billion CNY	-11.15%
2022 FY	-954.36 Million CNY	-113232.7%
2022 Q4	-435.94 Thousand CNY	15.91%
2022 Q2	-518.42 Thousand CNY	-0.42%
2021 FY	-842.09 Thousand CNY	99.83%
2021 Q2	-325.82 Thousand CNY	-4.14%
2021 Q4	-516.27 Thousand CNY	-58.45%
2020 Q4	-312.85 Thousand CNY	-60.07%
2020 FY	-508.3 Million CNY	-118.55%
2020 Q2	-195.44 Thousand CNY	-45.78%
2019 Q4	-134.07 Thousand CNY	-36.11%
2019 Q2	-98.5 Thousand CNY	0.0%
2019 FY	-232.57 Million CNY	-214288.3%
2018 FY	-108.48 Thousand CNY	99.77%
2017 FY	-46.21 Million CNY	14.77%
2017 Q4	-23.2 Thousand CNY	-0.86%
2017 Q2	-23 Thousand CNY	-84.27%
2016 Q4	-12.48 Thousand CNY	70.08%
2016 Q2	-41.73 Thousand CNY	0.0%
2016 FY	-54.22 Million CNY	-373.96%
2015 FY	-11.44 Million CNY	-37.09%
2014 FY	-8.34 Million CNY	0.0%

Peer Net Income Comparison of Kintor Pharmaceutical Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	1596.727%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	6249.681%